Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Dec 27, 2021; 13(12): 1615-1627
Published online Dec 27, 2021. doi: 10.4240/wjgs.v13.i12.1615
Published online Dec 27, 2021. doi: 10.4240/wjgs.v13.i12.1615
Table 4 Adjuvant therapy for recurrence after liver transplantation for unresectable colorectal cancer liver metastasis
Ref. | Overall survival (months) | Die/alive | Recurrence | Adjuvant therapy post recurrence after LT |
Yang et al[67] | 34 | 0/1 | Yes | Chemotherapy |
Lerut et al[68] | 28 | 3/1 | Yes, 4, 6, 47 mo | Chemotherapy |
Toso et al[66] | 6/6 | Median DFS 6 mo | 5 chemotherapy; 1 radiotherapy | |
Hagness[39] | 27 | 6/15 | Median DFS 19 mo | 11 Chemotherapy; 1 TACE; 7 Radiation therapy; 11 Re-resection |
Smedman et al[25] | 18 | 5/5 | Median DFS 8 mo | 3 Chemotherapy combined radiation therapy; 2 Chemotherapy; 1 Radiation; 1 Surgery |
Dueland et al[10] | 36 | 2/13 | Median DFS 8 mo | 6 Surgery; 2 Surgery combined Radiation therapy; 2 Chemotherapy |
Hrehoreţ et al[64] | 20 | 0/1 | Yes, 6 wk | Chemotherapy |
- Citation: Cui X, Geng XP, Zhou DC, Yang MH, Hou H. Advances in liver transplantation for unresectable colon cancer liver metastasis. World J Gastrointest Surg 2021; 13(12): 1615-1627
- URL: https://www.wjgnet.com/1948-9366/full/v13/i12/1615.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i12.1615